Funder: Cancer Research UK
Due Dates (Anticipated): May 2026 (Final submission) | June 2026 (Committee review)
Funding Amounts: No external grant funding; in-kind support for early-stage drug development and clinical translation.
Summary: Provides in-kind project management and development resources to advance novel cancer therapeutics from preclinical stages to early clinical trials.
Key Information: Applicants must contact the Centre for Drug Development before applying; support is provided in-kind, not as cash funding.